72878-2LOINC 2.82
UGT2B15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
UGT2B15 gene prod met act imp Bld/T-Imp
Definition
- Overall predicted phenotype for drug metabolism for all markers and/or individual UGT2B15 alleles identified in a patient. The predicted phenotypes are derived from reference literature.
Component
- UGT2B15 gene product metabolic activity interpretation
Specimen / system
- Bld/Tiss
Class
- MOLPATH.PHARMG
Property
- Imp
Scale
- Ord
Method
- Molgen
Related names
- Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Genetics; Heredity; Heritable; HLUG4; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 2 family, polypeptide
B15; UDPGT 2B8; UDPGT2B15; UDPGTH3; UGT2B15 gene prod met act imp; UGT2B8; WB; Whole blood; Whole blood or Tissue
Index terms
- Activ
- Actvty
- Blood
- Drug metabolism
- Gene prod met act imp
- Genetics
- Heredity
- Heritable
- HLUG4
- Impression
- Impression/interpretation of study
- Impressions
- Inherited
- Interp
- Interpret
- Interpretation
- Interpt
- Intrp
- Molecular genetics
- Molecular pathology
- MOLPATH
- MOLPATH.PHARMG
- Movements
- Ordinal
- PCR
- Phenotype
- Point in time
- QL
- Qual
- Qualitative
- Random
- Screen
- Tissue
- Tissue, unspecified
- UDP glucuronosyltransferase 2 family, polypeptide B15
- UDPGT 2B8
- UDPGT2B15
- UDPGTH3
- UGT2B15 gene prod met act imp
- UGT2B8
3 further terms